Myung SK et al
Botanical compounds in the glucose-management supplement category can have additive effects with prescription glucose-lowering medications, and professional guidance is the appropriate safeguard here
Common GLP-1 side effects often include nausea, constipation, diarrhea, vomiting, reflux, abdominal discomfort, reduced appetite, and fatigue
The quite unexpected positive cardiorenal outcomes that have emerged from the cardiovascular outcomes trials (CVOTs) with both glucagon like peptide-1 receptors agonists (GLP-1RA) and sodium-glucose co-transporter 2 (SGLT-2) inhibitors have produced a shift of diabetes management from the meticulous glycemic control alone to the simultaneous improvement of CV outcomes
These discussions often center on everyday experiences with GLP-1 medications, including how dosing choices affect comfort, cost, and consistency